A detailed history of Intrust Bank Na transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Intrust Bank Na holds 40,338 shares of ADMA stock, worth $862,023. This represents 0.08% of its overall portfolio holdings.

Number of Shares
40,338
Previous 31,302 28.87%
Holding current value
$862,023
Previous $349,000 130.95%
% of portfolio
0.08%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$11.21 - $20.03 $101,293 - $180,991
9,036 Added 28.87%
40,338 $806,000
Q2 2024

Aug 08, 2024

BUY
$5.98 - $11.18 $35,730 - $66,800
5,975 Added 23.59%
31,302 $349,000
Q1 2024

May 09, 2024

BUY
$4.4 - $6.74 $4,866 - $7,454
1,106 Added 4.57%
25,327 $167,000
Q4 2023

Feb 05, 2024

BUY
$3.08 - $4.52 $30,775 - $45,163
9,992 Added 70.22%
24,221 $109,000
Q3 2023

Nov 13, 2023

BUY
$3.47 - $4.61 $49,374 - $65,595
14,229 New
14,229 $50,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.2B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.